Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017 (2017), Article ID 8248175, 14 pages
https://doi.org/10.1155/2017/8248175
Research Article

Type II Endometrial Cancer Overexpresses NILCO: A Preliminary Evaluation

1Department of Microbiology, Biochemistry and Immunology, Morehouse School of Medicine, Atlanta, GA, USA
2Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA, USA
3Department of Obstetrics and Gynecology, Morehouse School of Medicine, Atlanta, GA, USA
4Department of Community Health & Preventive Medicine, Morehouse School of Medicine, Atlanta, GA, USA

Correspondence should be addressed to Ruben Rene Gonzalez-Perez; ude.msm@zelaznogr

Received 12 January 2017; Accepted 27 April 2017; Published 4 June 2017

Academic Editor: Eric A. Singer

Copyright © 2017 Danielle Daley-Brown et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Daley-Brown, G. M. Oprea-Ilies, R. Lee, R. Pattillo, and R. R. Gonzalez-Perez, “Molecular cues on obesity signals, tumor markers and endometrial cancer,” Hormone Molecular Biology and Clinical Investigation, vol. 21, no. 1, pp. 89–106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  2. R. L. Siegel, K. D. Miller, and A. Jemal, “Cancer statistics, 2015,” CA Cancer Journal for Clinicians, vol. 65, no. 1, pp. 5–29, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Collins, K. Holcomb, E. Chapman-Davis, D. Khabele, and J. H. Farley, “Gynecologic cancer disparities: a report from the health disparities taskforce of the Society of Gynecologic Oncology,” Gynecologic Oncology, vol. 133, no. 3, pp. 353–361, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. V. W. Setiawan, H. P. Yang, M. C. Pike et al., “Type I and II endometrial cancers: have they different risk factors?” Journal of Clinical Oncology, vol. 31, no. 20, pp. 2607–2618, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. R. R. Barakat, M. Markman, and M. Randall, “Corpus: epithelial tumors,” Principles and Practice of Gynecologic Oncology, pp. 683–686, 2009. View at Google Scholar
  6. C. A. Swanson, N. Potischman, G. D. Wilbanks et al., “Relation of endometrial cancer risk to past and contemporary body size and body fat distribution,” Cancer Epidemiology Biomarkers & Prevention, vol. 2, no. 4, pp. 321–327, 1993. View at Google Scholar
  7. L. Lu, H. Risch, M. L. Irwin et al., “Long-term overweight and weight gain in early adulthood in association with risk of endometrial cancer,” International Journal of Cancer, vol. 129, no. 5, pp. 1237–1243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Purdie and A. Green, “Epidemiology of endometrial cancer,” In Best Practice and Research in Clinical Obstetrics and Gynaecology, vol. 15, no. 3, pp. 341–354, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Basen-Engquist and M. Chang, “Obesity and cancer risk: recent review and evidence,” Current Oncology Reports, vol. 13, no. 1, pp. 71–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. R. R. Gonzalez, C. Simon, P. Caballero-Campo et al., “Leptin and reproduction,” Human Reproduction Update, vol. 6, no. 3, pp. 290–300, 2000. View at Publisher · View at Google Scholar
  11. K. Laud, I. Gourdou, L. Pessemesse, J. Djiane, and J. P. Peyrat, “Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line,” Molecular and Cellular Endocrinology, vol. 188, no. 1-2, pp. 219–226, 2002. View at Publisher · View at Google Scholar
  12. S. Guo, M. Liu, G. Wang, M. Torroella-Kouri, and R. R. Gonzalez-Perez, “Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells,” Biochimica et Biophysica Acta, vol. 1825, no. 2, pp. 207–222, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Ishikawa, J. Kitayama, and H. Nagawa, “Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer,” Clinical Cancer Research, vol. 10, no. 13, pp. 4325–4331, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Guo and R. R. Gonzalez-Perez, “Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptin-induced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer,” PloS One, vol. 6, no. 6, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Battle, C. Gillespie, A. Quarshie et al., “Obesity induced a leptin-Notch signaling Axis in breast cancer,” International Journal of Cancer, vol. 134, no. 7, pp. 1605–1616, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. S. S. Yuan, K. B. Tsai, Y. F. Chung et al., “Aberrant expression and possible involvement of the leptin receptor in endometrial cancer,” Gynecologic Oncology, vol. 92, no. 3, pp. 769–775, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Guo, M. Liu, and R. R. Gonzalez-Perez, “Role of Notch and its oncogenic signaling crosstalk in breast cancer,” Biochimica et Biophysica Acta, vol. 1815, no. 2, pp. 197–213, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Newman and R. R. Gonzalez-Perez, “Leptin–cytokine crosstalk in breast cancer,” Molecular and Cellular Endocrinology, vol. 382, no. 1, pp. 570–582, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Zhou, S. Guo, and R. R. Gonzalez-Perez, “Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling,” British Journal of Cancer, vol. 104, no. 1, pp. 128–137, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Hainaud, J. O. Contrerès, A. Villemain et al., “The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions,” Cancer Research, vol. 66, no. 17, pp. 8501–8510, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. R. R. Gonzalez, S. Cherfils, M. Escobar et al., “Leptin signaling promotes the growth of mammary tumors and increases the expression of vascular endothelial growth factor (VEGF) and its receptor type two (VEGF-R2),” Journal of Biological Chemistry, vol. 281, no. 36, pp. 26320–26328, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Lanier, C. Gillespie, M. Leffers et al., “Leptin-induced transphosphorylation of vascular endothelial growth factor receptor increases Notch and stimulates endothelial cell angiogenic transformation,” The International Journal of Biochemistry & Cell Biology, vol. 79, 2016. View at Publisher · View at Google Scholar · View at Scopus
  23. L. S. Colbert, K. Wilson, S. Kim et al., “NILCO biomarkers in breast cancer from Chinese patient,” BMC Cancer, vol. 14, no. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Cobellis, F. Caprio, E. Trabucco et al., “The pattern of expression of Notch protein members in normal and pathological endometrium,” Journal of Anatomy, vol. 213, no. 4, pp. 464–472, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Carino, A. B. Olawaiye, S. Cherfils et al., “Leptin regulation of pro-angiogenic molecules in benign and cancer endometrial cells,” International Journal of Cancer, vol. 123, no. 12, pp. 2782–2790, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. R. R. Gonzalez, K. Leary, J. C. Petrozza, and P. C. Leavis, “Leptin regulation of the interleukin 1 (IL-1) system in human endometrial cells,” Molecular Human Reproduction, vol. 9, no. 3, pp. 151–158, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Harmon, A. Harbuzariu, V. Lanier et al., “Nanoparticle-linked antagonist for leptin signaling inhibition in breast cancer,” World Journal of Clinical Oncology, vol. 8, no. 1, pp. 54–66, 2016. View at Publisher · View at Google Scholar
  28. C. Korcha, M. A. Spillmanb, T. A. Jackson et al., “DNA profiling analysis of endometrial and ovarian cell lines reveals misidentification, redundancy and contamination,” Gynecologic Oncology, vol. 127, no. 1, pp. 241–248, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Benedet, H. Bender, H. Ngan, and S. Percorell, “FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers,” International Journal of Gynaecology and Obstetrics, vol. 70, no. 2, pp. 209–622, 2000. View at Google Scholar
  30. S. Percorelli, “Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium,” International Journal of Gynaecology and Obstetrics, vol. 105, no. 2, pp. 103-104, 2009. View at Google Scholar
  31. E. E. Calle, C. Rodriguez, K. Walker-Thurmond, and M. J. Thun, “Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults,” The New England Journal of Medicine, vol. 348, no. 17, pp. 1625–1638, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Petridou, M. Blechri, N. Dessypris et al., “Leptin and body max index in relation to endometrial cancer risk,” Annals of Nutrition & Metabolism, vol. 46, no. 3-4, pp. 147–151, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Henson and V. D. Castracane, “Leptin: roles and regulation in primate pregnancy,” Seminars in Reproductive Medicine, vol. 20, no. 2, pp. 113–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. L. M. Méndez-López, A. Zavala-Pompa, and E. I. Cortés-Gutiérrez, “Leptin receptor expression during the progression of endometrial carcinoma is correlated with estrogen and progesterone receptors,” Archives of Medical Science, vol. 13, no. 1, pp. 228–235, 2017. View at Publisher · View at Google Scholar
  35. Y. Afshar, A. Stanculescu, and L. Miele, “The role of chorionic gonadotropin and Notch1 in implantation,” Journal of Assisted Reproduction and Genetics, vol. 24, no. 7, pp. 296–302, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Suzuki, D. Aoki, N. Susumu, Y. Udagawa, and S. Nozawa, “Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers,” International Journal of Oncology, vol. 17, no. 6, pp. 1131–1139, 2000. View at Publisher · View at Google Scholar
  37. V. Jonusiene, A. Sasnauskiene, N. Lachej et al., “Down-regulated expression of Notch signaling molecules in human endometrial cancer,” Medical Oncology, vol. 30, no. 1, pp. 1–7, 2013. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Lee, A. Sehrawat, and S. V. Singh, “Withaferin a causes activation of Notch2 and Notch4 in human breast cancer cells,” Breast Cancer Research and Treatment, vol. 136, no. 1, pp. 45–56, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. H. B. Salvesen, O. E. Iversen, and L. A. Akslen, “Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study,” Journal of Clinical Oncology, vol. 17, no. 5, p. 1382, 1999. View at Google Scholar
  40. M. Saegusa, M. Hashimura, T. Yoshida, and I. Okayasu, “ß-catenin mutations and aberrant nuclear expression during endometrial tumorigenesis,” British Journal of Cancer, vol. 84, no. 2, pp. 209–217, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. F. Linkov, R. Edwards, J. Balk et al., “Endometrial hyperplasia, endometrial cancer and prevention: gaps in existing research of modifiable risk factors,” European Journal of Cancer, vol. 44, no. 12, pp. 1632–1644, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. C. C. Lipsey, A. Harbuzariu, D. Daley-Brown, and R. R. Gonzalez-Perez, “Oncogenic role of leptin and NILCO in cancer,” World Journal of Methodology, vol. 6, no. 1, pp. 43–55, 2016. View at Publisher · View at Google Scholar